UTAH MEDICAL PRODUCTS, INC. (UTMD) Operating income 2016–2025
UTAH MEDICAL PRODUCTS, INC. (UTMD) annual operating income history from SEC filings — each fiscal year as reported.
$11.4MFY2025 · since FY2016: $16.2M → $11.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $11.4M | -16.1% |
| FY2024 | $13.6M | -19.0% |
| FY2023 | $16.8M | -15.2% |
| FY2022 | $19.8M | +4.8% |
| FY2021 | $18.9M | +37.7% |
| FY2020 | $13.7M | -22.3% |
| FY2019 | $17.6M | -5.7% |
| FY2018 | $18.7M | -1.7% |
| FY2017 | $19.0M | +17.4% |
| FY2016 | $16.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More UTMD financial trends
UTMD RevenueUTMD Net incomeUTMD Net marginUTMD Gross profitUTMD Gross marginUTMD Operating marginUTMD Operating cash flowUTMD Free cash flowUTMD Capital expendituresUTMD Return on equityUTMD Stock buybacksUTMD Dividends paidUTMD Total assetsUTMD Total liabilitiesUTMD Shareholders’ equityUTMD overview →